1. Home
  2. JAGX vs SPRC Comparison

JAGX vs SPRC Comparison

Compare JAGX & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • SPRC
  • Stock Information
  • Founded
  • JAGX 2013
  • SPRC 2004
  • Country
  • JAGX United States
  • SPRC Israel
  • Employees
  • JAGX N/A
  • SPRC N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • SPRC Biotechnology: Pharmaceutical Preparations
  • Sector
  • JAGX Health Care
  • SPRC Health Care
  • Exchange
  • JAGX Nasdaq
  • SPRC Nasdaq
  • Market Cap
  • JAGX 3.4M
  • SPRC 3.0M
  • IPO Year
  • JAGX N/A
  • SPRC N/A
  • Fundamental
  • Price
  • JAGX $2.35
  • SPRC $5.14
  • Analyst Decision
  • JAGX Strong Buy
  • SPRC
  • Analyst Count
  • JAGX 1
  • SPRC 0
  • Target Price
  • JAGX $60.00
  • SPRC N/A
  • AVG Volume (30 Days)
  • JAGX 75.4K
  • SPRC 41.7K
  • Earning Date
  • JAGX 08-14-2025
  • SPRC 02-15-2025
  • Dividend Yield
  • JAGX N/A
  • SPRC N/A
  • EPS Growth
  • JAGX N/A
  • SPRC N/A
  • EPS
  • JAGX N/A
  • SPRC N/A
  • Revenue
  • JAGX $11,552,000.00
  • SPRC $1,306,000.00
  • Revenue This Year
  • JAGX $22.41
  • SPRC N/A
  • Revenue Next Year
  • JAGX $30.00
  • SPRC N/A
  • P/E Ratio
  • JAGX N/A
  • SPRC N/A
  • Revenue Growth
  • JAGX 13.93
  • SPRC N/A
  • 52 Week Low
  • JAGX $1.93
  • SPRC $4.14
  • 52 Week High
  • JAGX $35.25
  • SPRC $37.59
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 46.26
  • SPRC 32.98
  • Support Level
  • JAGX $2.02
  • SPRC $5.06
  • Resistance Level
  • JAGX $2.33
  • SPRC $5.59
  • Average True Range (ATR)
  • JAGX 0.14
  • SPRC 0.48
  • MACD
  • JAGX 0.07
  • SPRC -0.19
  • Stochastic Oscillator
  • JAGX 58.33
  • SPRC 2.90

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: